CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Colombia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Colombia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Colombian healthcare market has significant potential for growth. The extensive health insurance system and presence of Free Trade Agreement (FTA) with the US are the main drivers for growth. The pharmaceutical value for Colombia in 2011 was $2.66B and declined to $1.71B in 2016 at negative CAGR of 8.5%.The pharmaceutical market is expected to reach $1.45B in 2022. The medical devices market in Colombia is mainly import-based. Colombia offers affordable private healthcare with better quality.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Colombia, and includes -
- An overview of the pharmaceutical markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Roche, Pfizer, Merck, Procaps and Sanofi)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Colombia
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- Porter’s five forces analysis for pharmaceutical market of Colombia
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Colombia healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Colombia healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Colombia healthcare market